| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | NEUTRAL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 1.19▲ | 1.19▲ | 1.19▲ | 1.17▲ | 1.21▲ |
| MA10 | 1.14▲ | 1.13▲ | 1.13▲ | 1.11▲ | 1.76▼ |
| MA20 | 1.11▲ | 1.13▲ | 1.12▲ | 1.19▲ | 1.82▼ |
| MA50 | 1.23▼ | 1.25▼ | 1.26▼ | 1.84▼ | 1.79▼ |
| MA100 | 1.29▼ | 1.44▼ | 1.55▼ | 1.79▼ | 3.39▼ |
| MA200 | 1.64▼ | 1.98▼ | 1.93▼ | 1.75▼ | 4.07▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.026▲ | 0.026▲ | 0.027▲ | 0.048▲ | -0.110▼ |
| RSI | 57.896▲ | 55.260▲ | 54.784▲ | 41.166▼ | 39.641▼ |
| STOCH | 98.937▲ | 91.497▲ | 91.497▲ | 61.741 | 12.626▼ |
| WILL %R | 0.000▲ | 0.000▲ | 0.000▲ | -30.240 | -85.508▼ |
| CCI | 118.341▲ | 120.644▲ | 120.644▲ | 70.724 | -83.964 |
|
Monday, November 02, 2026 05:01 AM
Special meeting of Chemomab shareholders to vote on the proposed merger scheduled for December 4, 2026 TEL AVIV, Israel, and DURHAM, N.C., Nov. 02, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: CMMB) (“Chemomab” ...
|
|
Monday, November 02, 2026 05:01 AM
Chemomab Therapeutics (Nasdaq: CMMB) and Scipher Medicine Corporation announced that the U.S. Securities and Exchange Commission declared effective the Registration Statement on Form S-4 filed in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 04/11/26 | 1.22 | 1.22 | 1.22 | 1.22 | 27,927 |
| 03/11/26 | 1.33 | 1.33 | 1.16 | 1.18 | 38,886 |
| 02/11/26 | 1.22 | 1.2295 | 1.15 | 1.18 | 76,438 |
| 30/10/26 | 1.1384 | 1.16 | 1.02 | 1.16 | 224,381 |
| 29/10/26 | 1.1009 | 1.19 | 1.09 | 1.09 | 40,832 |
| 28/10/26 | 1.05 | 1.1548 | 1.045 | 1.10 | 21,849 |
| 27/10/26 | 1.06 | 1.06 | 1.01 | 1.05 | 8,808 |
| 26/10/26 | 1.10 | 1.10 | 0.9201 | 1.00 | 34,415 |
| 23/10/26 | 1.10 | 1.205 | 1.01 | 1.03 | 25,900 |
| 22/10/26 | 1.15 | 1.24 | 1.01 | 1.08 | 54,800 |
|
|
||||
|
|
||||
|
|